Panibon, Vicenta .

HRN: 02-17-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFTRIAXONE 1G (VIAL)
10/06/2023
10/13/2023
IV
2 Grams
OD
Cap MR
Waiting Final Action 
10/06/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/06/2023
10/13/2023
ORAL
500mg
OD
Cap MR
Waiting Final Action 
10/13/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/13/2023
10/19/2023
IV
2.25
Q8
Cholecystitis
Waiting Final Action 
10/17/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/17/2023
10/24/2023
PO
500mg
OD
CAP-MR
Waiting Final Action 
10/18/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/18/2023
10/25/2023
PO
500
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: